Pfizer to buy cancer drug maker Trillium for $2.3B

[JacksinPA]

Pfizer to buy cancer drug maker Trillium for $2.3B

Pfizer said it will pay $18.50 a share for the Cambridge, Massachusetts-based drug maker Trillium.

nypost.com

Pfizer, maker of one of the top selling COVID-19 vaccines, said Monday it plans to buy all the shares of cancer drug maker Trillium that it doesn’t own for $2.26 billion.

Pfizer said it will pay $18.50 a share for the Cambridge, Massachusetts-based drug maker. The price represents a 118-percent premium to the stock’s 60-day weighted average price, the companies said in a press release.

Shares of Trillium skyrocketed 188 percent to $17.56, while Pfizer’s stock rose nearly 3.7 percent in early-day trading.

Last September, Pfizer invested $25 million in Trillium as part of its Breakthrough Growth Initiative, when Jeff Settleman, senior vice president of Pfizer’s oncology research and development group, was added to Trillium’s scientific advisory board.
======================================================================
I'm very happy that I bought Pfizer stock a while back. Very aggressive & well-managed company.

Trillium focuses on blood cancers like leukemia, multiple myeloma and lymphoma.

 

[Rexedgar]

Pfizer ought to have some spare cash laying around…..

 

[EdwinWillers]

...funded in full by revenues from their covid drug no doubt.

 

[Integrityrespec]

Pfizer ought to have some spare cash laying around…..

More money to put in the pockets of political campaigns.